Showing results (111-120 of 516) with videos related to
Sort By:
Pageof 52
The Journal of Clinical Investigation|December 1, 1984
Tissue-type plasminogen activator increases the binding of glu-plasminogen to clotsC Tran-Thang, E K Kruithof, F BachmannExpert Opinion on Biological Therapy|December 12, 2018
A vaccine against Alzheimer`s disease: anything left but faith?Martin F Bachmann, Gary T Jennings, Monique VogelCurrent Opinion in Clinical Nutrition and Metabolic Care|November 27, 2025
Core outcome sets and trials of nutrition and metabolism interventionsAnnika Reintam Blaser, Thomas Davies, Kaspar F BachmannImmunological Reviews|May 31, 2020
The 3Ds in virus-like particle based-vaccines: "Design, Delivery and Dynamics"Mona O Mohsen, Gilles Augusto, Martin F BachmannDrug Discovery Today|October 24, 2006
A second vaccine revolution for the new epidemics of the 21st centuryMark R Dyer, Wolfgang A Renner, Martin F BachmannInternational Archives of Allergy and Immunology|June 17, 2020
Strategies to Prevent SARS-CoV-2-Mediated Eosinophilic Disease in Association with COVID-19 Vaccination and InfectionHans-Uwe Simon, Alexander V Karaulov, Martin F BachmannEuropean Radiology|April 7, 2004
MR imaging of compartment syndrome of the lower leg: a case control studyM B Rominger, C J Lukosch, G F BachmannMolecular Immunology|May 14, 2004
Enhanced apoptotic activity of a structurally optimized form of galectin-1Patrick Bättig, Philippe Saudan, Tea Gunde, et al.Journal of Immunology (Baltimore, Md. : 1950)|April 22, 2004
Influenza A vaccine based on the extracellular domain of M2: weak protection mediated via antibody-dependent NK cell activityAndrea Jegerlehner, Nicole Schmitz, Tazio Storni, et al.Biotechniques|August 25, 2005
Hybrid Sindbis/Epstein-Barr virus episomal expression vector for inducible production of proteinsLidia Ivanova, Johanna Brändli, Philippe Saudan, et al.Pageof 52